The knowledge paper points to fragmented health data, limited clinical evidence and the absence of predictable lifecycle-based regulation for adaptive AI as key barriers to wider adoption
India Medical Device 2026 highlights the need for deeper domestic value addition, advanced manufacturing, predictable regulation and stronger industry-startup collaboration
ICMR, CSIR and DBT actively promoting and strengthening the use of advanced in-vitro, cell-based, three-dimensional tissue models and computational methods
The ministry has incorporated procedural safeguards, including the issuance of a show-cause notice before any debarment order is passed
Anil Matai, Director General, OPPI calls for structured and regular engagement between regulators and industry to strengthen trust, transparency, and collaboration within India’s pharma regulatory ecosystem
The country now ranks third globally in the total number of organ transplants after the United States and China though a significant gap remains between organ demand and availability
Recommendations were made at MTaI's closed-door roundtable organised as part of the association's 10th anniversary that brought together policymakers, diplomatic representatives from various embassies, along with trade experts and MedTech industry leaders
New platform aims to accelerate approvals, strengthen transparency and enhance global confidence in India's pharmaceutical regulatory system
After delayed environmental clearance, the project has now gained pace with around 20% of Phase-I site development completed, and nearly 98% of the 15 MLD water supply and groundwater recharge system completed
The drugs that received one time exemption to ease shortages include Carboplatin Injection (10 mg/ml), Cisplatin Injection (1 mg/ml), Anti-Tetanus Immunoglobulin 250 IU and Anti-Tetanus Immunoglobulin 500 IU
Union health minister JP Nadda to outline government's MedTech vision at DoP and FICCI’s flagship conference on August 7-8 in New Delhi
While Technology Development Board (TDB) has approved 22 projects worth Rs. 4,744 crore, BIRAC has shortlisted eight projects involving Rs. 390.35 crore for financial support
New recommendations especially for Africa and South-East Asia introduce SSG-free therapies, improve treatment for visceral leishmaniasis and PKDL
Government integrates Ayush into medical hub plans while advancing research, quality standards and global collaboration
Domestic production begins for MRI, CT, LINACs, heart valves, stents and other high-end medical devices
AI, genomics, NGS and Amaravati Quantum Valley to power end-to-end cancer care across the state's public healthcare system
Collaborations will focus on herbal medicine standardisation, quality assessment of assistive devices, and inclusive pharmacovigilance initiatives aligned with the Viksit Bharat vision
Updated code mandates ethics committees, compliance disclosures, and annual marketing expenditure reporting
PMBJP now offers 2,110 medicines and 315 surgicals and medical devices at prices 50–80% lower than branded alternatives
The industry expects tariff certainty to support long-term planning, encourage sustained export growth, and reinforce India's position as a trusted global supplier of affordable medicines
Subscribe To Our Newsletter & Stay Updated
